OTC Healthcare in Australia
Euromonitor International's OTC Healthcare in Australia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 125 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
OTC healthcare continues to grow steadily
Steady growth was maintained in OTC healthcare over the review period, with particularly strong performances by NRT smoking cessation aids and emergency contraception. Growth in NRT smoking cessation aids was driven by the government’s efforts to increase public awareness of smoking-related health ailments, as well as the imposition of restrictions on smoking in public. Meanwhile, emergency contraception was propelled by the positive reception of a new product riding on the convenience and ease of use factor. With the rising prevalence of obesity in Australia, there was moderate growth in OTC obesity and digestive remedies, as consumers embarked on more weight-loss activities and sought remedies for gastrointestinal complaints, which tend to be exacerbated by weight issues.
Symbion Health Ltd undergoes multiple acquisitions
Symbion Health Ltd had an eventful 2008, with considerable takeover activity over the course of the year. Within months of acquiring Symbion in April 2008, Primary Health Care Ltd announced its intention to sell the company to fund the debt resulting from the takeover. Significant interest was expressed by domestic players, such as Sigma Pharmaceuticals Pty Ltd, Australian Pharmaceutical Industries Ltd and Metcash Trading Ltd. Metcash Trading saw this as an opportunity to diversify away from the company’s core business of grocery wholesaling and retailing. However, in August 2008, foreign-based Sanofi-Aventis eventually secured the consumer division of Symbion Health Ltd.
Symbion Health Ltd retains lead in OTC healthcare
Despite undergoing two rounds of acquisition, Symbion Health Ltd maintained the lead in OTC healthcare in 2008, due largely to its continuing strong performance in vitamins and dietary supplements. The company is also present in analgesics, digestive remedies, medicated skin care and adult mouth care. Symbion Health was followed by Johnson & Johnson Pacific Pty Ltd, domestic company Blackmores Ltd and GlaxoSmithKline Australia Pty Ltd. Johnson & Johnson Pacific Pty Ltd performed well in several OTC healthcare sectors, including medicated skin care and digestive remedies, while GlaxoSmithKline continued to feature strongly in analgesics and NRT smoking cessation aids.
Retail pressure heat up as grocery retailers continue to strengthen
Chemists/pharmacies continue to face increasing competition from grocery retailers, especially major supermarkets such as Woolworths and Coles. To raise their competitiveness, chemists/pharmacies engaged in price discounting, but this met with aggressive rivalry from Internet retailers. On the other hand, direct selling remains a small contributor to OTC healthcare in 2008. This channel deals mainly in nutritional products and carries a smaller range of OTC healthcare products as compared to grocery retailers.
Moderate growth expected over forecast period
OTC healthcare is expected to achieve moderate growth over the forecast period, with continuing strong growth in emergency contraception and NRT smoking cessation aids. The interest in preventive health measures will also drive moderate increases in vitamins and dietary supplements. The ageing of the population is expected to contribute to growth in digestive remedies and eye care, while rising obesity in Australia will encourage a pick-up in OTC obesity products.
Table of contents
OTC HEALTHCARE IN AUSTRALIA : MARKET INSIGHT
EXECUTIVE SUMMARY
OTC healthcare continues to grow steadily
Symbion Health Ltd undergoes multiple acquisitions
Symbion Health Ltd retains lead in OTC healthcare
Retail pressure heat up as grocery retailers continue to strengthen
Moderate growth expected over forecast period
KEY TRENDS AND DEVELOPMENTS
Convenience featuring highly in both product development and distribution
Preference for branded products over generics and private label
Child-specific products experience growth
Negative publicity associated with side effects of OTC healthcare
Rising retail pressures for chemists/pharmacies
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2008
DEFINITIONS
Summary 2 Research Sources
LOCAL COMPANY PROFILES - AUSTRALIA
EGO PHARMACEUTICALS PTY LTD - OTC HEALTHCARE - AUSTRALIA
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Ego Pharmaceuticals Pty Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Ego Pharmaceuticals Pty Ltd: Competitive Position 2008
HERRON PHARMACEUTICALS PTY LTD - OTC HEALTHCARE - AUSTRALIA
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Herron Pharmaceuticals Pty Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 6 Herron Pharmaceuticals Pty Ltd: Competitive Position 2008
INOVA PHARMACEUTICALS (AUSTRALIA) PTY LTD - OTC HEALTHCARE - AUSTRALIA
STRATEGIC DIRECTION
KEY FACTS
Summary 7 iNova Pharmaceuticals (Australia) Pty Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 8 iNova Pharmaceuticals (Australia) Pty Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 9 iNova Pharmaceuticals (Australia) Pty Ltd: Competitive Position 2008
PHARMACARE LABORATORIES PTY LTD - OTC HEALTHCARE - AUSTRALIA
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Pharmacare Laboratories Pty Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 11 Pharmacare Laboratories Pty Ltd: Competitive Position 2008
SYMBION HEALTH LTD - OTC HEALTHCARE - AUSTRALIA
STRATEGIC DIRECTION
KEY FACTS
Summary 12 Symbion Health Ltd: Key Facts
Summary 13 Symbion Health Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 14 Symbion Health Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 15 Symbion Health Ltd: Competitive Position 2008
ANALGESICS IN AUSTRALIA
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 16 Analgesics Company Shares by Value 2004-2008
Table 17 Analgesics Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN AUSTRALIA
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 22 Sales of Decongestants by Type: Value 2003-2008
Table 23 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 26 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 27 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 28 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 29 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 30 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN AUSTRALIA
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 33 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 34 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 35 Herbal vs Standard Digestive Remedies 2003-2008
Table 36 Digestive Remedies Company Shares by Value 2004-2008
Table 37 Digestive Remedies Brand Shares by Value 2005-2008
Table 38 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 39 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN AUSTRALIA
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 40 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 41 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 42 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 43 Medicated Skin Care Company Shares by Value 2004-2008
Table 44 Medicated Skin Care Brand Shares by Value 2005-2008
Table 45 Acne Treatments Brand Shares by Value 2005-2008
Table 46 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 47 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 48 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN AUSTRALIA
HEADLINES
TRENDS – VITAMINS
TRENDS – DIETARY SUPPLEMENTS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 49 Dietary Supplements: Brand Ranking by Positioning 2008
Table 50 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 51 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 52 Folic Acid v Other B Vitamins 2004-2008
Table 53 Dietary Supplements by Positioning 2006-2008
Table 54 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 55 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 56 Vitamins Brand Shares by Value 2005-2008
Table 57 Dietary Supplements Brand Shares by Value 2005-2008
Table 58 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 59 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN AUSTRALIA
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 60 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 61 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 62 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 63 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 64 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 65 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 66 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 67 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE IN AUSTRALIA
HEADLINES
SECTOR DATA
Table 68 Sales of Eye Care by Subsector: Value 2003-2008
Table 69 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 70 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 71 Eye Care Company Shares by Value 2004-2008
Table 72 Eye Care Brand Shares by Value 2005-2008
Table 73 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 74 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN AUSTRALIA
HEADLINES
SECTOR DATA
Table 75 Sales of Ear Care: Value 2003-2008
Table 76 Sales of Ear Care: % Value Growth 2003-2008
Table 77 Ear Care Company Shares by Value 2004-2008
Table 78 Ear Care Brand Shares by Value 2005-2008
Table 79 Forecast Sales of Ear Care: Value 2008-2013
Table 80 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN AUSTRALIA
HEADLINES
SECTOR DATA
Table 81 Sales of Adult Mouth Care: Value 2003-2008
Table 82 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 83 Adult Mouth Care Company Shares by Value 2004-2008
Table 84 Adult Mouth Care Brand Shares by Value 2005-2008
Table 85 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 86 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN AUSTRALIA
HEADLINES
SECTOR DATA
Table 87 Sales of Calming and Sleeping Products: Value 2003-2008
Table 88 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 89 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 90 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 91 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 92 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN AUSTRALIA
HEADLINES
SECTOR DATA
Table 93 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 94 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 95 Wound Treatments Company Shares by Value 2004-2008
Table 96 Wound Treatments Brand Shares by Value 2005-2008
Table 97 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 98 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
OTC OBESITY IN AUSTRALIA
HEADLINES
SECTOR DATA
Table 99 Sales of OTC Obesity: Value 2004-2008
Table 100 Sales of OTC Obesity: % Value Growth 2004-2008
Table 101 OTC Obesity Company Shares by Value 2004-2008
Table 102 OTC Obesity Brand Shares by Value 2005-2008
Table 103 Forecast Sales of OTC Obesity: Value 2008-2013
Table 104 Forecast Sales of OTC Obesity: % Value Growth 2008-2013
EMERGENCY CONTRACEPTION IN AUSTRALIA
HEADLINES
SECTOR DATA
Table 105 Sales of Emergency Contraception: Value 2004-2008
Table 106 Sales of Emergency Contraception: % Value Growth 2004-2008
Table 107 Emergency Contraception Company Shares by Value 2004-2008
Table 108 Emergency Contraception Brand Shares by Value 2005-2008
Table 109 Forecast Sales of Emergency Contraception: Value 2008-2013
Table 110 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013